Cargando…

Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab

Inflammatory bowel diseases are chronic inflammation of the intestinal mucosa characterized by relapsing–remitting cycle periods of variable duration. Infliximab (IFX) was the first monoclonal antibody used for the treatment of Crohn’s disease and ulcerative colitis (UC). High variability between tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blais, Anne, Lan, Annaïg, Blachier, François, Benamouzig, Robert, Jouet, Pauline, Couvineau, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253642/ https://www.ncbi.nlm.nih.gov/pubmed/37298505 http://dx.doi.org/10.3390/ijms24119554

Ejemplares similares

Mucosal healing progression after acute colitis in mice
por: Vidal-Lletjós, Sandra, et al.
Publicado: (2019)

Dietary Protein Intake Level Modulates Mucosal Healing and Mucosa-Adherent Microbiota in Mouse Model of Colitis
por: Vidal-Lletjós, Sandra, et al.
Publicado: (2019)

Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
por: Couvineau, Alain, et al.
Publicado: (2021)

Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa?
por: Vidal-Lletjós, Sandra, et al.
Publicado: (2017)

Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice
por: Blais, Anne, et al.
Publicado: (2017)

The Orexin receptors: Structural and anti-tumoral properties
por: Couvineau, Alain, et al.
Publicado: (2022)

Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
por: Alain, Couvineau, et al.
Publicado: (2021)

Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
por: Couvineau, Alain, et al.
Publicado: (2019)

Infliximab use in ulcerative colitis flare with clostridium difficile infection: A report of two cases and literature review
por: Romana, Bhupinder S., et al.
Publicado: (2018)

The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
por: Couvineau, Alain, et al.
Publicado: (2018)

Listeria Rhombencephalitis Complicating Anti-TNF Treatment during an Acute Flare of Crohn's Colitis
por: Stratton, L., et al.
Publicado: (2016)

Lactoferrin Supplementation during Gestation and Lactation Is Efficient for Boosting Rat Pup Development
por: Blais, Anne, et al.
Publicado: (2022)

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
por: Shinzaki, Shinichiro, et al.
Publicado: (2017)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies
por: Beigel, Florian, et al.
Publicado: (2014)

Mucosal healing in ulcerative colitis: surveillance or colectomy?
por: Andrisani, Gianluca, et al.
Publicado: (2013)

Ulcerative Colitis-associated Spondyloarthritis Successfully Treated with Infliximab in the Absence of Enhanced TNF-α Responses
por: Fujita, Shunsuke, et al.
Publicado: (2022)

Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
por: Becquet, Laurine, et al.
Publicado: (2019)

Here to Heal: Mucosal CD74 Signaling in Colitis
por: Hoffman, Jill M., et al.
Publicado: (2020)

Efficacy of infliximab treatment on the mucosal healing of different intestinal segments in patients with ileocolonic Crohn’s disease
por: Wu, Yaling, et al.
Publicado: (2020)

Intussusception in the Setting of an Ulcerative Colitis Flare
por: Abed, Varag, et al.
Publicado: (2022)

Hyperosmolar environment and intestinal epithelial cells: impact on mitochondrial oxygen consumption, proliferation, and barrier function in vitro
por: Grauso, Marta, et al.
Publicado: (2019)

Tetraspanin CD9 Limits Mucosal Healing in Experimental Colitis
por: Saiz, María Laura, et al.
Publicado: (2017)

Novel oral-targeted therapies for mucosal healing in ulcerative colitis
por: Antonelli, Elisabetta, et al.
Publicado: (2018)

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
por: Koga, Akihiro, et al.
Publicado: (2018)

Inflammation-sleep interface in brain disease: TNF, insulin, orexin
por: Clark, Ian A, et al.
Publicado: (2014)

The Orexin-A/OX1R System Induces Cell Death in Pancreatic Cancer Cells Resistant to Gemcitabine and Nab-Paclitaxel Treatment
por: Voisin, Thierry, et al.
Publicado: (2022)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
por: Fonseca, Ashley, et al.
Publicado: (2021)

Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing
por: Ahmad, Rizwan, et al.
Publicado: (2023)

Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice
por: Pineton de Chambrun, G, et al.
Publicado: (2014)

In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
por: Dayot, Stéphanie, et al.
Publicado: (2018)

Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results
por: Süha, Çetin, et al.
Publicado: (2014)

Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab
por: Unlu, Mehmet, et al.
Publicado: (2014)

The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
por: Seo, Hyun Il, et al.
Publicado: (2014)

Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013)

Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis
por: Kono, Masashi, et al.
Publicado: (2023)

Kaposi Sarcoma Mimicking Acute Flare of Ulcerative Colitis
por: Kumar, Vivek, et al.
Publicado: (2017)

Remission of ulcerative colitis flare-up induced by nivolumab
por: Iwamoto, Maho, et al.
Publicado: (2020)

AZD-1222: Flare of ulcerative colitis: case report
Publicado: (2022)

Listeria Monocytogenes Septicemia in the Setting of an Ulcerative Colitis Flare
por: Seraphin, Michael J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ailjdtcbvs7hia3t7td951gf3